Publication | Closed Access

Evaluation of the effect of oral clodronate on skeletal metastases with type 1 collagen metabolites. A controlled trial of the finnish prostate cancer group

Bone DiseaseType 1UrologyBone HealthMedicinePharmacologySkeletal MetastasesProstatic DiseaseMetabolic Bone DiseaseOncologyOsteoporosisBone MetabolismCancer ResearchOral Clodronate